Mike Anderson

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
6 83% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return -51%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance

Positions

Position Company Period
Chief Executive Officer, Director Avadel Pharmaceuticals PLC June 22, 2012 - Dec. 30, 2018
Chief Executive Officer Avadel Pharmaceuticals PLC March 13, 2012 - June 22, 2012
Mike Anderson's trades of Avadel Pharmaceuticals PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2018-08-14 2018-08-10
S Sale
89,476 +3.4%
187.41
US$877,762 		89,476 +3.4% 187.41 US$877,762
2018-06-27 2018-06-26
B Purchase
54,904 +12.5%
164.61
US$1,173,140 		54,904 +12.5% 164.61 US$1,173,140
2016-09-07 2016-09-02
B Purchase
59,941 +21.5%
253.35
US$2,856,635 		59,941 +21.5% 253.35 US$2,856,635
2016-05-16 2016-05-12
B Purchase
5,000 +3.9%
8.84
US$44,200 		5,000 +3.9% 8.84 US$44,200
2016-03-21 2016-03-18
B Purchase
5,000 +4.0%
11.04
US$55,220 		5,000 +4.0% 11.04 US$55,220
2016-03-16 2016-03-14
B Purchase
10,000 +8.8%
9.74
US$97,350 		10,000 +8.8% 9.74 US$97,350